Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hematol Oncol Stem Cell Ther ; 16(1): 315-319, 2023 Jan 12.
Artigo em Inglês | MEDLINE | ID: mdl-36634274

RESUMO

Checkpoint inhibitors, cancer immunotherapies, are the new forms of treatment for gray zone lymphoma, a rare subtype that combines the characteristics of both Hodgkin and non-Hodgkin disease forms. Programmed cell death protein 1/programmed cell death ligand 1 (PD-L1/PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) modulate the immune system function. Immunological checkpoints can be stimulatory or inhibitory, and tumors can use these checkpoints to protect against immune system attacks. This is a case report of a difficult diagnosis and describes the most current treatment using checkpoint inhibitors, through the review of the clinical record of a patient diagnosed with gray area lymphoma in August 2019, using a descriptive and cross-sectional analysis of the clinical history and disease evolution. The case showed that pembrolizumab therapy is an effective treatment option for patients with rare gray zone lymphoma refractory to different lines of treatment. Both the diagnosis and treatment of gray area lymphoma remain a challenge for the medical and multiprofessional teams, and collaboration between them ensured effective treatment for the patient.


Assuntos
Linfoma não Hodgkin , Linfoma , Neoplasias , Humanos , Estudos Transversais , Linfoma/patologia , Resultado do Tratamento , Antígeno B7-H1/metabolismo
2.
J Med Virol ; 93(8): 4908-4914, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-33788308

RESUMO

We evaluate the genetic characterization of 132 HIV-1 pol sequences from children and adolescents undergoing antiretroviral therapy in Northeast Brazil. Phylogenetic and recombination analyses were performed using the maximum likelihood method using SeaView version 4 and SIMPLOT software. Most individuals harbored HIV-1 B (84.8%) and BF recombinants (9.8%), although other non-B subtypes were detected: HIV-1 C (1.5%), HIV-1 F (2.4%), and BC recombinants (1.5%). Antiretroviral resistance was 47% (95% confidence interval [CI]: 38.7%-55.4%). Non-nucleoside reverse transcriptase inhibitors (NNRTIs) showed higher frequencies of primary mutations, with 40.9% (95% CI: 32.9%-49.4%), followed by nucleoside reverse transcriptase inhibitors (NRTI) and protease inhibitors (PIs) with 34.8% (95% CI: 27.3-43.3) and 6.1% (95% CI: 3.1%-11.5%), respectively. Among NRTIs, higher resistance levels were observed for abacavir, emtricitabine, and lamivudine; for NNRTI, nevirapine and efavirenz. The most common primary mutations found were M184V (29.5%), K103N (25%), M41L (9.8%), T215Y (8.3%), and G190A (8.3%). Our findings highlight the importance of surveillance of resistance mutations, which contributes to the continuous updating and implementation of preventive measures to decrease mother-to-child-transmission and transmitted drug resistance.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Farmacorresistência Viral/genética , Infecções por HIV/tratamento farmacológico , HIV-1/genética , Adolescente , Brasil/epidemiologia , Criança , Pré-Escolar , Farmacorresistência Viral/efeitos dos fármacos , Genótipo , Infecções por HIV/epidemiologia , Infecções por HIV/virologia , HIV-1/classificação , HIV-1/efeitos dos fármacos , HIV-1/isolamento & purificação , Humanos , Mutação , Filogenia
3.
Perspect Psychiatr Care ; 55(1): 119-125, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30189115

RESUMO

PURPOSE: Our aim was to evaluate the effects of deep breathing exercises in subjects with bipolar disorder. DESIGN AND METHODS: This was an open-label, uncontrolled clinical trial with three assessments: preintervention, postintervention, and follow-up. FINDINGS: The Hamilton Anxiety Rating Scale, BECK-A, Hamilton Depression Rating Scale, and Young Mania Rating Scale had significant preintervention, postintervention, and follow-up differences. The results indicated that the deep breathing protocol was effective in reducing anxiety levels in patients with bipolar disorder. The deep breathing protocol has no negative side effects and might be applied to decrease anxiety symptoms in individuals with bipolar disorder. PRACTICE IMPLICATIONS: The results provide direction for providing quality care that reduces anxiety levels in patients with bipolar disorder.


Assuntos
Ansiedade/terapia , Transtorno Bipolar/terapia , Terapia de Relaxamento/métodos , Respiração , Adulto , Brasil , Exercício Físico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Escalas de Graduação Psiquiátrica
4.
J Clin Anesth ; 12(1): 61-3, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10773511

RESUMO

A patient with an epidural catheter for postoperative analgesia developed a stroke in association with a hypotensive episode resulting from a bolus of local anesthetic. After undergoing resection for femoral chondrosarcoma under epidural anesthesia, the patient received a continuous infusion of epidural morphine for postoperative analgesia. Lidocaine 1% (10 mL in divided doses) was administered through the catheter for breakthrough pain. The patient experienced a hypotensive episode and was noted to have a motor and cortical sensory deficit of the left arm and leg 8 hours after the hypotensive episode. Clinical presentation and subsequent workup were consistent with a watershed infarction. The patient recovered full neurologic function before discharge. Postoperative hypotension from epidural analgesia may be associated with stroke; however, a cause-and-effect relationship usually cannot be established with certainty.


Assuntos
Analgesia Epidural/efeitos adversos , Anestésicos Locais/efeitos adversos , Lidocaína/efeitos adversos , Complicações Pós-Operatórias , Acidente Vascular Cerebral/etiologia , Idoso , Analgésicos Opioides/uso terapêutico , Anestesia Epidural , Braço/inervação , Infarto Cerebral/etiologia , Condrossarcoma/cirurgia , Neoplasias Femorais/cirurgia , Humanos , Hipotensão/etiologia , Perna (Membro)/inervação , Masculino , Morfina/uso terapêutico , Transtornos dos Movimentos/etiologia , Transtornos de Sensação/etiologia
5.
Anesthesiology ; 90(3): 697-700, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10078669

RESUMO

BACKGROUND: Nausea and vomiting are the most frequent problems after minor ambulatory surgical procedures. The agents used to induce and maintain anesthesia may modify the incidence of emesis. When neuromuscular blockade is antagonized with anticholinesterases, atropine or glycopyrrolate is used commonly to prevent bradycardia and excessive oral secretions. This study was designed to evaluate the effect of atropine and glycopyrrolate on postoperative vomiting in children. METHODS: Ninety-three patients undergoing tonsillectomy with or without adenoidectomy were studied. After inhalation induction of anesthesia with nitrous oxide, oxygen, and halothane, anesthesia was maintained with a nitrous oxide-oxygen mixture, halothane, morphine, and atracurium. Patients were randomized to receive, in a double-blinded manner, either 15 microg/kg atropine or 10 microg/kg glycopyrrolate with 60 microg/kg neostigmine to reverse neuromuscular blockade. Patient recovery, the incidence of postoperative emesis, antiemetic therapy, and the duration of postoperative hospital stay were assessed. RESULTS: There were no significant differences in age, gender, weight, or discharge time from the postanesthesia care unit or the hospital between the groups. Twenty-four hours after operation, the incidence of vomiting in the atropine group (56%) was significantly less than in the glycopyrrolate group (81%; P<0.05). There was no significant difference between the atropine and glycopyrrolate groups in the number of patients who required antiemetics or additional analgesics. CONCLUSIONS: In children undergoing tonsillectomy with or without adenoidectomy, reversal of neuromuscular blockade with atropine and neostigmine is associated with a lesser incidence of postoperative emesis compared with glycopyrrolate and neostigmine.


Assuntos
Adenoidectomia/efeitos adversos , Atropina/administração & dosagem , Glicopirrolato/administração & dosagem , Parassimpatolíticos/administração & dosagem , Náusea e Vômito Pós-Operatórios/prevenção & controle , Tonsilectomia/efeitos adversos , Adolescente , Anestésicos Inalatórios/administração & dosagem , Criança , Pré-Escolar , Método Duplo-Cego , Feminino , Humanos , Masculino , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...